These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33042403)

  • 21. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
    Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist.
    Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
    Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.
    Pawar RD; Ramanjaneyulu A; Kulkarni OP; Lech M; Segerer S; Anders HJ
    J Am Soc Nephrol; 2007 Jun; 18(6):1721-31. PubMed ID: 17460144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/
    Machida T; Sakamoto N; Ishida Y; Takahashi M; Fujita T; Sekine H
    Front Immunol; 2018; 9():1191. PubMed ID: 29892304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice.
    Nozaki Y; Kitching AR; Akiba H; Yagita H; Kinoshita K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1210-21. PubMed ID: 24623145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C; Izumino K; Iida H; Fujita M; Asaka M; Takata M; Sasayama S
    Nephron; 1993; 64(3):471-5. PubMed ID: 7688103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.
    Kim YY; Park KT; Jang SY; Lee KH; Byun JY; Suh KH; Lee YM; Kim YH; Hwang KW
    Arthritis Res Ther; 2017 Sep; 19(1):211. PubMed ID: 28950886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niclosamide ethanolamine improves kidney injury in db/db mice.
    Han P; Zhan H; Shao M; Wang W; Song G; Yu X; Zhang C; Ge N; Yi T; Li S; Sun H
    Diabetes Res Clin Pract; 2018 Oct; 144():25-33. PubMed ID: 30081104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis.
    Ijima S; Saito Y; Nagaoka K; Yamamoto S; Sato T; Miura N; Iwamoto T; Miyajima M; Chikenji TS
    Front Immunol; 2022; 13():960601. PubMed ID: 36466895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
    Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
    Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin attenuates lupus nephritis in MRL/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF).
    Li Q; Tan S; Xu K; Fu X; Yu J; Yang H; Wang H
    Int J Clin Exp Pathol; 2019; 12(6):2075-2083. PubMed ID: 31934029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niclosamide ethanolamine inhibits artery constriction.
    Li SL; Yan J; Zhang YQ; Zhen CL; Liu MY; Jin J; Gao JL; Xiao XL; Shen X; Tai Y; Hu N; Zhang XZ; Sun ZJ; Dong DL
    Pharmacol Res; 2017 Jan; 115():78-86. PubMed ID: 27872020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.